Windsor, CA, United States of America

Nancy Klassen



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Nancy Klassen: Pioneering Pharmaceutical Innovations

Introduction: Nancy Klassen, a prolific inventor hailing from Windsor, CA (US), is a trailblazer in the field of pharmaceutical formulations. With a remarkable portfolio of three patents under her belt, Nancy has revolutionized the encapsulation of naproxen into soft gel dosage units, elevating stability, concentration, and bioavailability in the process.

Latest Patents: Nancy's latest patent showcases her expertise in formulating naproxen for soft gel encapsulation. This innovative invention not only enhances the stability and concentration of naproxen but also allows for the incorporation of other active pharmaceutical ingredients. Her patent also introduces a process for increasing the achievable concentration of the active NSAID pharmaceutical ingredient, leading to more efficient dosage units.

Career Highlights: Nancy Klassen has made significant contributions to the pharmaceutical industry through her work at Catalent Ontario Limited and Accucaps Industries Limited. Her dedication to innovation and commitment to excellence have solidified her reputation as a leader in the field of pharmaceutical formulations.

Collaborations: Throughout her career, Nancy has collaborated with esteemed professionals in the industry, including John Lopez and Peter Robert Draper. These collaborations have not only enriched her expertise but have also led to the development of groundbreaking pharmaceutical products.

Conclusion: Nancy Klassen stands as a beacon of inspiration in the world of pharmaceutical innovations. Her unwavering passion, coupled with her drive for excellence, has cemented her legacy as a pioneering inventor. Nancy's work continues to shape the future of technology, leaving an indelible mark on generations to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…